表紙:DNAおよび遺伝子クローニングサービスの世界市場 (2022年~2031年):製品タイプ (遺伝子合成・カスタムクローニング・サブクローニング・その他)・用途 (DNAシーケンシング・突然変異誘発・ジェノタイピング) 別の産業分析・規模・シェア・成長・動向・予測
市場調査レポート
商品コード
1166026

DNAおよび遺伝子クローニングサービスの世界市場 (2022年~2031年):製品タイプ (遺伝子合成・カスタムクローニング・サブクローニング・その他)・用途 (DNAシーケンシング・突然変異誘発・ジェノタイピング) 別の産業分析・規模・シェア・成長・動向・予測

DNA and Gene Cloning Services Market (Product Type: Gene Synthesis, Custom Cloning, Sub-cloning and Others; Application: DNA Sequencing, Mutagenesis, and Genotyping) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

出版日: | 発行: Transparency Market Research | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
DNAおよび遺伝子クローニングサービスの世界市場 (2022年~2031年):製品タイプ (遺伝子合成・カスタムクローニング・サブクローニング・その他)・用途 (DNAシーケンシング・突然変異誘発・ジェノタイピング) 別の産業分析・規模・シェア・成長・動向・予測
出版日: 2022年10月25日
発行: Transparency Market Research
ページ情報: 英文 150 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のDNAおよび遺伝子クローニングサービスの市場を調査し、市場概要、市場成長への各種影響因子の分析、規制シナリオ、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 序文

第2章 前提と調査手法

第3章 エグゼクティブサマリー:世界のDNAおよび遺伝子クローニングサービス市場

第4章 市場概要

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 世界のDNAおよび遺伝子クローニングサービス市場の分析・予測

第5章 主な洞察

  • 主要3社
  • 主なM&A
  • 規制シナリオ
  • COVID-19の産業への影響(バリューチェーンと短期・中期・長期の影響)

第6章 世界のDNAおよび遺伝子クローニングサービス市場の分析・予測:製品タイプ別

  • イントロダクション・定義
  • 主な調査結果/展開
  • 市場規模・予測
    • 遺伝子合成
    • カスタムクローニング
    • サブクローニング
    • その他
  • 市場の魅力

第7章 世界のDNAおよび遺伝子クローニングサービス市場の分析・予測:用途別

  • イントロダクション・定義
  • 主な調査結果/展開
  • 市場規模・予測
    • DNAシーケンシング
    • 突然変異誘発
    • ジェノタイピング
    • その他
  • 市場の魅力

第8章 世界のDNAおよび遺伝子クローニングサービス市場の分析・予測:エンドユーザー別

  • イントロダクション・定義
  • 主な調査結果/展開
  • 市場規模・予測
    • 学術・研究機関
    • 製薬・バイオテクノロジー企業
    • その他

第9章 世界のDNAおよび遺伝子クローニングサービス市場の分析・予測:地域別

  • 主な調査結果
  • 市場規模・予測
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ

第10章 北米のDNAおよび遺伝子クローニングサービス市場の分析・予測

第11章 欧州のDNAおよび遺伝子クローニングサービス市場の分析・予測

第12章 ラテンアメリカのDNAおよび遺伝子クローニングサービス市場の分析・予測

第13章 中東・アフリカのDNAおよび遺伝子クローニングサービス市場の分析・予測

第14章 競合情勢

  • 参入企業・競合マトリックス
  • 市場シェア分析:企業別
  • 企業プロファイル
    • Aragen Life Sciences
    • Bio-Techne
    • Charles River Laboratories
    • Curia
    • Eurofins
    • GenScript
    • Integrated DNA Technologies
    • MedGenome
    • Sino Biological
    • Syngene
    • Twist Bioscience
図表

List of Tables

  • Table 01: Global DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 03: Global DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 07: North America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 08: North America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 11: Europe DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: Europe DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 15: Asia Pacific DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 16: Asia Pacific DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 19: Latin America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Latin America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 23: Middle East & Africa DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Middle East & Africa DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 1: Global DNA and Gene Cloning Services Market, by Product Type, 2021 and 2031
  • Figure 2: Global DNA and Gene Cloning Services Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 3: Global DNA and Gene Cloning Services Market (US$ Mn), by Gene Synthesis, 2017-2031
  • Figure 4: Global DNA and Gene Cloning Services Market (US$ Mn), by Custom Cloning, 2017-2031
  • Figure 5: Global DNA and Gene Cloning Services Market (US$ Mn), by Sub-cloning, 2017-2031
  • Figure 6: Global DNA and Gene Cloning Services Market (US$ Mn), by Others, 2017-2031
  • Figure 7: Global DNA and Gene Cloning Services Market, by Application, 2021 and 2031
  • Figure 8: Global DNA and Gene Cloning Services Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 9: Global DNA and Gene Cloning Services Market (US$ Mn), by DNA Sequencing, 2017-2031
  • Figure 10: Global DNA and Gene Cloning Services Market (US$ Mn), by Mutagenesis, 2017-2031
  • Figure 11: Global DNA and Gene Cloning Services Market (US$ Mn), by Genotyping, 2017-2031
  • Figure 12: Global DNA and Gene Cloning Services Market (US$ Mn), by Others, 2017-2031
  • Figure 13: Global DNA and Gene Cloning Services Market, by End-user, 2021 and 2031
  • Figure 14: Global DNA and Gene Cloning Services Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 15: Global DNA and Gene Cloning Services Market (US$ Mn), by Academic & Research Institutes
  • Figure 16: Global DNA and Gene Cloning Services Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017-2031
  • Figure 17: Global DNA and Gene Cloning Services Market (US$ Mn), by Others, 2017-2031
  • Figure 18: Global DNA and Gene Cloning Services Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 19: Global DNA and Gene Cloning Services Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 20: North America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 21: North America DNA and Gene Cloning Services Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 22: North America DNA and Gene Cloning Services Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 23: North America DNA and Gene Cloning Services Market, by Product Type, 2021 and 2031
  • Figure 24: North America DNA and Gene Cloning Services Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 25: North America DNA and Gene Cloning Services Market, by Application, 2021 and 2031
  • Figure 26: North America DNA and Gene Cloning Services Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 27: North America DNA and Gene Cloning Services Market, by End-user, 2021 and 2031
  • Figure 28: North America DNA and Gene Cloning Services Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 29: Europe DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 30: Europe DNA and Gene Cloning Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 31: Europe DNA and Gene Cloning Services Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 32: Europe DNA and Gene Cloning Services Market, by Product Type, 2021 and 2031
  • Figure 33: Europe DNA and Gene Cloning Services Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 34: Europe DNA and Gene Cloning Services Market, by Application, 2021 and 2031
  • Figure 35: Europe DNA and Gene Cloning Services Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 36: Europe DNA and Gene Cloning Services Market, by End-user, 2021 and 2031
  • Figure 37: Europe DNA and Gene Cloning Services Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 38: Asia Pacific DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 41: Asia Pacific DNA and Gene Cloning Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 42: Asia Pacific DNA and Gene Cloning Services Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 43: Asia Pacific DNA and Gene Cloning Services Market, by Product Type, 2021 and 2031
  • Figure 44: Asia Pacific DNA and Gene Cloning Services Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 45: Asia Pacific DNA and Gene Cloning Services Market, by Application, 2021 and 2031
  • Figure 46: Asia Pacific DNA and Gene Cloning Services Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 47: Asia Pacific DNA and Gene Cloning Services Market, by End-user, 2021 and 2031
  • Figure 48: Asia Pacific DNA and Gene Cloning Services Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 49: Latin America DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 50: Latin America DNA and Gene Cloning Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 51: Latin America DNA and Gene Cloning Services Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 52: Latin America DNA and Gene Cloning Services Market, by Product Type, 2021 and 2031
  • Figure 53: Latin America DNA and Gene Cloning Services Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 54: Latin America DNA and Gene Cloning Services Market, by Application, 2021 and 2031
  • Figure 55: Latin America DNA and Gene Cloning Services Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 56: Latin America DNA and Gene Cloning Services Market, by End-user, 2021 and 2031
  • Figure 57: Latin America DNA and Gene Cloning Services Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 58: Middle East & Africa DNA and Gene Cloning Services Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 59: Middle East & Africa DNA and Gene Cloning Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 60: Middle East & Africa DNA and Gene Cloning Services Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 61: Middle East & Africa DNA and Gene Cloning Services Market, by Product Type, 2021 and 2031
  • Figure 62: Middle East & Africa DNA and Gene Cloning Services Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 63: Middle East & Africa DNA and Gene Cloning Services Market, by Application, 2021 and 2031
  • Figure 64: Middle East & Africa DNA and Gene Cloning Services Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 65: Middle East & Africa DNA and Gene Cloning Services Market, by End-user, 2021 and 2031
  • Figure 66: Middle East & Africa DNA and Gene Cloning Services Market Attractiveness Analysis, by End-user, 2022-2031
目次
Product Code: TMRGL85195

TMR's report on the global DNA and gene cloning services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global DNA and gene cloning services market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global DNA and gene cloning services market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the DNA and gene cloning services market.

The report delves into the competitive landscape of the global DNA and gene cloning services market. Key players operating in the global DNA and gene cloning services market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global DNA and gene cloning services market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives

2. Assumptions and Research Methodology

3. Executive Summary: Global DNA and Gene Cloning Services Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global DNA and Gene Cloning Services Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Top 3 players operating in the market space
  • 5.2. Key Mergers & Acquisitions
  • 5.3. Regulatory Scenario
  • 5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short-/ Mid-/ Long-term impact)

6. Global DNA and Gene Cloning Services Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Gene Synthesis
    • 6.3.2. Custom Cloning
    • 6.3.3. Sub-cloning
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global DNA and Gene Cloning Services Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. DNA Sequencing
    • 7.3.2. Mutagenesis
    • 7.3.3. Genotyping
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global DNA and Gene Cloning Services Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Academic & Research Institutes
    • 8.3.2. Pharmaceutical & Biotechnology Companies
    • 8.3.3. Others

9. Global DNA and Gene Cloning Services Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa

10. North America DNA and Gene Cloning Services Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2017-2031
    • 10.2.1. Gene Synthesis
    • 10.2.2. Custom Cloning
    • 10.2.3. Sub-cloning
    • 10.2.4. Others
  • 10.3. Market Value Forecast, by Application, 2017-2031
    • 10.3.1. DNA Sequencing
    • 10.3.2. Mutagenesis
    • 10.3.3. Genotyping
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Academic & Research Institutes
    • 10.4.2. Pharmaceutical & Biotechnology Companies
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe DNA and Gene Cloning Services Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. Gene Synthesis
    • 11.2.2. Custom Cloning
    • 11.2.3. Sub-cloning
    • 11.2.4. Others
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. DNA Sequencing
    • 11.3.2. Mutagenesis
    • 11.3.3. Genotyping
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Academic & Research Institutes
    • 11.4.2. Pharmaceutical & Biotechnology Companies
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Latin America DNA and Gene Cloning Services Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Gene Synthesis
    • 12.2.2. Custom Cloning
    • 12.2.3. Sub-cloning
    • 12.2.4. Others
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. DNA Sequencing
    • 12.3.2. Mutagenesis
    • 12.3.3. Genotyping
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Academic & Research Institutes
    • 12.4.2. Pharmaceutical & Biotechnology Companies
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. Brazil
    • 12.5.2. Mexico
    • 12.5.3. Rest of Latin America
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Middle East & Africa DNA and Gene Cloning Services Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Gene Synthesis
    • 13.2.2. Custom Cloning
    • 13.2.3. Sub-cloning
    • 13.2.4. Others
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. DNA Sequencing
    • 13.3.2. Mutagenesis
    • 13.3.3. Genotyping
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Academic & Research Institutes
    • 13.4.2. Pharmaceutical & Biotechnology Companies
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. GCC Countries
    • 13.5.2. South Africa
    • 13.5.3. Rest of Middle East & Africa
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis, by Company, 2021
  • 14.3. Company Profiles
    • 14.3.1. Aragen Life Sciences
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Company Financials
      • 14.3.1.3. Growth Strategies
      • 14.3.1.4. SWOT Analysis
    • 14.3.2. Bio-Techne
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Company Financials
      • 14.3.2.3. Growth Strategies
      • 14.3.2.4. SWOT Analysis
    • 14.3.3. Charles River Laboratories
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Company Financials
      • 14.3.3.3. Growth Strategies
      • 14.3.3.4. SWOT Analysis
    • 14.3.4. Curia
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Company Financials
      • 14.3.4.3. Growth Strategies
      • 14.3.4.4. SWOT Analysis
    • 14.3.5. Eurofins
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Company Financials
      • 14.3.5.3. Growth Strategies
      • 14.3.5.4. SWOT Analysis
    • 14.3.6. GenScript
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Company Financials
      • 14.3.6.3. Growth Strategies
      • 14.3.6.4. SWOT Analysis
    • 14.3.7. Integrated DNA Technologies
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Company Financials
      • 14.3.7.3. Growth Strategies
      • 14.3.7.4. SWOT Analysis
    • 14.3.8. MedGenome
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Company Financials
      • 14.3.8.3. Growth Strategies
      • 14.3.8.4. SWOT Analysis
    • 14.3.9. Sino Biological
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Company Financials
      • 14.3.9.3. Growth Strategies
      • 14.3.9.4. SWOT Analysis
    • 14.3.10. Syngene
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Company Financials
      • 14.3.10.3. Growth Strategies
      • 14.3.10.4. SWOT Analysis
    • 14.3.11. Twist Bioscience
      • 14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.11.2. Company Financials
      • 14.3.11.3. Growth Strategies
      • 14.3.11.4. SWOT Analysis